Evidence map›Paper›PMID 34193554›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Inhibition of Epigenetic Modifiers LSD1 and HDAC1 Blocks Rod Photoreceptor Death in Mouse Models of Retinitis Pigmentosa.

Evgenya Y Popova, Yuka Imamura Kawasawa, Samuel Shao-Min Zhang, Colin J Barnstable

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Exploring Histone Modifications in Inherited Retinal Disorders.Advances in experimental medicine and biology · 2025
    Review
  8. Review
  9. Dysregulation of histone deacetylases in ocular diseases.Archives of pharmacal research · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Deletion of histone demethylaseFrontiers in cellular neuroscience · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Evgenya Y PopovaDepartment of Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, Pennsylvania 17033.
Yuka Imamura KawasawaDepartments of Pharmacology and Biochemistry and Molecular Biology, Institute for Personalized Medicine, Penn State College of Medicine, Hershey, Pennsylvania 17033.
Samuel Shao-Min ZhangDepartment of Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, Pennsylvania 17033.
Colin J BarnstableDepartment of Neural and Behavioral Sciences, Penn State University College of Medicine, Hershey, Pennsylvania 17033 cbarnstable@psu.edu.
Penn State Milton S. Hershey Medical Center · USPennsylvania State University · US

Funding

Epigenetic modifiers as therapeutic agents to combat retinal degenerationR21EY029992 · NEI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI BARNSTABLE, COLIN J · 2019 to 2020
$420k
NEI NIH HHS R21 EY029992
6 · The paper itself

Abstract

Epigenetic modifiers are increasingly being investigated as potential therapeutics to modify and overcome disease phenotypes. Diseases of the nervous system present a particular problem as neurons are postmitotic and demonstrate relatively stable gene expression patterns and chromatin organization. We have explored the ability of epigenetic modifiers to prevent degeneration of rod photoreceptors in a mouse model of retinitis pigmentosa (RP), using rd10 mice of both sexes. The histone modification eraser enzymes lysine demethylase 1 (LSD1) and histone deacetylase 1 (HDAC1) are known to have dramatic effects on the development of rod photoreceptors. In the RP mouse model, inhibitors of these enzymes blocked rod degeneration, preserved vision, and affected the expression of multiple genes including maintenance of rod-specific transcripts and downregulation of those involved in inflammation, gliosis, and cell death. The neuroprotective activity of LSD1 inhibitors includes two pathways. First, through targeting histone modifications, they increase accessibility of chromatin and upregulate neuroprotective genes, such as from the Wnt pathway. We propose that this process is going in rod photoreceptors. Second, through nonhistone targets, they inhibit transcription of inflammatory genes and inflammation. This process is going in microglia, and lack of inflammation keeps rod photoreceptors alive.

Indexed as

AnimalsCell DeathDisease Models, AnimalEpigenesis, GeneticFemaleHistone Deacetylase 1Histone Deacetylase InhibitorsHistone DemethylasesMaleMiceMice, Inbred C57BLNerve DegenerationRetinal Rod Photoreceptor CellsRetinitis PigmentosaTranylcypromineHdac1 protein, mouseHistone Deacetylase 1Histone Deacetylase InhibitorsHistone DemethylasesKDM1a protein, mouseTranylcyprominechromatinepigeneticLSD1rd10retina degenerationrod photoreceptor

Identifiers

PMID34193554
PMCPMC8336706
OpenAlexW3175052176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.